Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Stroke Volume

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

E-selectin and transferrin receptor functionalized synthetic miRNA nanoshuttles with therapeutic potential in stroke.

Drug delivery and translational research·2026

Same author

Development of immunoliposomes with E-Selectin affinity to target endothelial inflammation: direct comparison of antibody types.

Journal of liposome research·2026

Same author

<i>OAS1</i> and <i>OAS3</i> genetic variants enhance inflammatory responses to SARS-CoV-2.

iScience·2025

Same author

Blood-brain barrier dysfunction in cerebral arteriovenous malformations. A murine model of hypoperfusion-reperfusion injury assessed with dynamic contrast-enhanced MRI.

Brain & spine·2025

Same author

Microglial Replacement Reverses Age-Associated Epigenetic Modifications Despite Accelerating Epigenetic Age.

Aging and disease·2025

Same author

Blood-Brain Barrier Disruption Predicts Poor Outcome in Subarachnoid Hemorrhage: A Dynamic Contrast-Enhanced MRI Study.

Stroke·2025

Search research articles

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

SIRT1 regulation modulates stroke outcome.

Valérie Petegnief¹, Anna M Planas

¹Department of Brain Ischemia and Neurodegeneration, Institute for Biomedical Research of Barcelona, Spanish Research Council, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain, valerie.petegnief@iibb.csic.es.

Translational Stroke Research

|December 11, 2013

Summary

Silent information regulator 1 (SIRT1) impacts cell survival during brain ischemia. This review examines SIRT1's role in stroke models, questioning its therapeutic potential for human stroke outcomes.

More Related Videos

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

Area of Science:

Biochemistry
Neuroscience
Molecular Biology

Background:

Silent information regulator 1 (SIRT1) is a NAD+-dependent deacetylase involved in gene expression, longevity, and metabolic adaptation to stress.
SIRT1 activation shows protective effects in neurodegenerative diseases.
The role of SIRT1 in acute nervous system injury, specifically brain ischemia, is under investigation.

Purpose of the Study:

To review the current understanding of SIRT1's contribution to cell death and survival in brain ischemia models.
To discuss the controversial role of SIRT1 activation in improving stroke outcomes.
To evaluate SIRT1 as a potential therapeutic target for human stroke.

Main Methods:

Literature review of studies on SIRT1 in cell and animal models of brain ischemia.
Analysis of data concerning SIRT1's impact on neuronal survival and death pathways.
Discussion of existing evidence regarding SIRT1 activation and stroke outcome.

Main Results:

SIRT1's function in brain ischemia models is complex and context-dependent.
Evidence suggests both protective and detrimental effects of SIRT1 activation in different ischemia scenarios.
The net effect of SIRT1 on stroke outcome remains a subject of debate.

Conclusions:

SIRT1 plays a significant, albeit controversial, role in the cellular response to brain ischemia.
Further research is needed to clarify SIRT1's precise mechanisms and therapeutic window in stroke.
SIRT1's viability as a therapeutic target for human stroke requires careful consideration of its dual roles.